BIOMAT Database Logo BIOMAT Database Logo

[Effectiveness of concomitant therapy with S-1, nedaplatin, and radiation for laryngeal cancer]. 2010

Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
Dept. of Otorhinolaryngology, Showa University, Fujigaoka Hospital.

Laryngeal cancer occurs more frequently in head and neck cancers, so there are a number of reports regarding the treatment results,wherein the therapeutic strategy and results are stable to some extent. However, due to the spread of chemoradiotherapy, there are differences in the larynx preservation rates for T2 and T3 cases, depending on the facility. Our department has been administering chemoradiotherapy for advanced cancer based on the perspective of conserving the organ and the function. We herein report our examination of 20 laryngeal cancer cases receiving concomitant therapy with S-1, Nedaplatin, and radiation (hereinafter, referred to as SN therapy) in our department from April 2005 to December 2008. The resulting complete response (CR) rate for the SN therapy was 82.4%, excluding T4 cases. Due to their refusal of surgery, 2 of 3 cases in which the SN therapy had been administered for T4 cases receiving SN therapy showed CR, wherein the CR rate in all cases after the SN therapy was 80. 0%. The larynx preservation rate after the SN therapy was 94.1%.

UI MeSH Term Description Entries
D007822 Laryngeal Neoplasms Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS. Cancer of Larynx,Laryngeal Cancer,Larynx Neoplasms,Cancer of the Larynx,Larynx Cancer,Neoplasms, Laryngeal,Cancer, Laryngeal,Cancer, Larynx,Cancers, Laryngeal,Cancers, Larynx,Laryngeal Cancers,Laryngeal Neoplasm,Larynx Cancers,Larynx Neoplasm,Neoplasm, Laryngeal,Neoplasm, Larynx,Neoplasms, Larynx
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009944 Organoplatinum Compounds Organic compounds which contain platinum as an integral part of the molecule. Compounds, Organoplatinum
D010094 Oxonic Acid Antagonist of urate oxidase. Oteracil
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207

Related Publications

Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
[Efficacy of concomitant therapy with S-1, CDGP, and radiation for laryngeal cancer].
October 2010, Gan to kagaku ryoho. Cancer & chemotherapy,
Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
[Combined preoperative therapy for oral cancer with nedaplatin and radiation].
March 2002, Gan to kagaku ryoho. Cancer & chemotherapy,
Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
[Nedaplatin (NDP)-combination therapy (NDP/5-FU,NDP/S-1) for oral cancer].
May 2007, Gan to kagaku ryoho. Cancer & chemotherapy,
Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
Chemotherapy and radiation therapy for laryngeal cancer.
August 1995, Seminars in speech and language,
Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
[Effectiveness of S-1 therapy for unresectable/advanced pancreas cancer].
September 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
March 2011, Japanese journal of clinical oncology,
Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
[RADIATION THERAPY OF LARYNGEAL CANCER].
January 1964, Radiobiologia, radiotherapia,
Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
[Laryngeal preservation for hypopharyngeal cancer by radiotherapy with S-1 and vitamin A(TAR therapy)].
May 2012, Gan to kagaku ryoho. Cancer & chemotherapy,
Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
Indications for radiation therapy in laryngeal cancer.
January 1960, The American journal of roentgenology, radium therapy, and nuclear medicine,
Toshikazu Shimane, and Tomoaki Mori, and Tomohiro Ono, and Aya Kaburagi, and Tetsuya Monden, and Ayako Furuya, and Kiyoaki Kamakazu, and Sei Kobayashi, and Takeyuki Sanbe, and Harumi Suzaki
[A case of hypopharyngeal cancer successfully treated with concurrent S-1, nedaplatin and radiotherapy].
April 2011, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!